BRCA MUTATED PANCREATIC CANCER

Clinical trials for BRCA MUTATED PANCREATIC CANCER explained in plain language.

Never miss a new study

Get alerted when new BRCA MUTATED PANCREATIC CANCER trials appear

Sign up with your email to follow new studies for BRCA MUTATED PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New drug combo targets BRCA cancers in early trial

Disease control Ongoing

This early-phase study tests a combination of two drugs, niraparib and dostarlimab, in 18 adults with BRCA-mutated breast, pancreas, or ovary cancer that has spread or cannot be surgically removed. Niraparib blocks a DNA repair protein in cancer cells, while dostarlimab helps the…

Matched conditions: BRCA MUTATED PANCREATIC CANCER

Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control

Last updated Jun 27, 2026 08:09 UTC

BRCA MUTATED PANCREATIC CANCER

Get alerted when new BRCA MUTATED PANCREATIC CANCER trials appear

New drug combo targets BRCA cancers in early trial